Innate and adaptive immune responses have an essential role in the development and progression of many cardio vascular diseases. The concept of atherosclerosis -the primary cause of coronary artery disease, stroke, and peripheral vascular disease -as a chronic inflammatory disease is widely accepted. Inflammation is also involved in the pathophysiology of atrial fibrillation, the most common cardiac arrhythmia. Defects in the resolution of inflammation promote the progression to vulnerable plaque in atherosclerosis, and altered immune responses can lead to cardiac remodelling after myocardial infarc tion. To highlight the importance of the immune sys tem in the pathophysiology of cardiovascular diseases, Nature Reviews Cardiology brings together a Collection 1 of Reviews and news articles that summarize our current knowledge and recent advances in this field.
Three Technical advances in imaging atherosclerotic plaques have provided unique opportunities in both research and clinical practice. Novel modalities for molecular imaging of human coronary arteries in vivo, such as the dualmodality optical coherence tomo graphy and nearinfrared autofluorescence, discussed in a News & Views article by Psaltis and Nicholls, have greatly enhanced imaging resolution and the capacity to detect and quantify pathological processes within the plaque. New PET tracers have emerged for track ing plaque inflammation, hypoxia, or calcification (summarized by Tarkin and colleagues in their Review), which can potentially be used as a markers of plaque vulnerability for risk stratification of patients.
Another issue that has received much attention over the past few years is therapies that target the immune response for the prevention and treatment of cardio vascular diseases. As described by Bäck and Hansson in their Review, therapies that are currently used or are under evaluation for other diseases are being explored as potential antiinflammatory therapies for athero sclerosis. In his Review, Frangogiannis highlights potential immunetargeted therapies to counter balance the destructive effects of cardiac remodelling after myo cardial damage. Antiinflammatory therapeutic strategies also have the potential to be used in atrial fibrillation, viral myocarditis, and recurrent pericarditis.
Improving our understanding of the inflammatory processes involved in the pathophysiology of cardio vascular diseases can lead to new opportunities for the management of these patients. Current therapeutic approaches to atherosclerosis and myocardial infarction focus on riskfactor reduction and revascularization; the aim of this Collection is to highlight the role of inflamma tory processes in cardiovascular disease and to identify novel antiinflammatory therapeutic approaches.
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